ISPOR Europe 2025
The Leading Global Conference for Health Economics and Outcomes Research ISPOR Europe 2025, the prem...
November 9 - November 12BIOCHINA2026 – Fusion Forward: Uniting the Global Biopharma Community in Suzhou
Suzhou, China – March 12–14, 2026 – The global biopharmaceutical industry will gather in Suzho...
March 12, 2026 - March 14, 2026London Biotechnology Show 2026
The London Biotechnology Show Returns: Bigger & Bolder for Its 3rd Edition! After two successful...
June 9, 2026 - June 10, 2026
In a surprising twist on public health, a recent study suggests that individuals exposed to sugar rationing early in life may enjoy a decreased risk of cardiovascular diseases in...
Dravet Syndrome, a severe form of childhood epilepsy, triggers a desperate search for effective treatments. Among these is Diacomit, an anti-epileptic drug showing promise in what is clinically termed...
Wayrilz, a promising therapy from Sanofi targeting immune thrombocytopenia (ITP), has drawn a favorable recommendation from the Committee for Medicinal Products for Human Use (CHMP) in the EU. This...
The European Medicines Agency (EMA) announces a significant update: the supply shortage of Fasturtec, a critical medication for hyperuricemia, has been successfully resolved. This news brings relief to healthcare...
Upcoming Meetings
Pharmacoeconomics
Latest NewsLatest
Sugar Rationing in Early Life Tied to Lower Adult Cardiovascular Risks
In a surprising twist on public health, a recent study suggests that individuals exposed to sugar rationing early in life may enjoy a decreased...
Malaysia MDA’s Policy Revamp Boosts Medical Device Market Access
Malaysia's Medical Device Authority (MDA) has made significant strides in facilitating market access for medical devices with its updated recognition policy. The changes, effective...
Germany’s Health Committee Initiates Review of Cystic Fibrosis Panels
In a significant move towards enhancing healthcare standards, Germany's Joint Federal Committee (G-BA), the supreme decision-making authority in German healthcare, has decided to revise...
G-BA Revises Guidelines for Home Nursing Care Services in Germany
In response to valuable feedback from healthcare professionals and stakeholders, the German Federal Joint Committee (G-BA) recently enacted pivotal changes to its guidelines governing...
Sonova Unveils Innovative Hearing Solutions at EUHA 2025
The longstanding challenge of enhancing speech clarity in noisy situations continues to trouble hearing aid users and hearing care providers. However, at the International...
Diacomit: A Hopeful Development for Severe Myoclonic Epilepsy
Dravet Syndrome, a severe form of childhood epilepsy, triggers a desperate search for effective treatments. Among these is Diacomit, an anti-epileptic drug showing promise...
G-BA Assigns IQWiG to Probe Links Between Surgery Volume and Quality in Pediatric Anorectal Malformations
The complexities surrounding the connection between the volume of medical procedures and the resulting quality of care are progressively emerging as significant concerns in...
Trastuzumab Deruxtecan Fails to Show Added Benefit in Breast Cancer Patients
The stakeholders in the medical community navigate the complex landscape of cancer treatment options with the release of the latest dossier assessment from the...
New Clinical Trials Information System Enhances Data Transparency
Clinical trials form the backbone of medical advancement, offering a systematic means for evaluating treatments and improving patient care. With the evolution of modern...
Laboratoire Aguettant Withdraws Application for Hydrocortisone Aguettant for Preterm Infants
Laboratoire Aguettant has encountered a setback in its journey to bring Hydrocortisone Aguettant to the market for the prevention of bronchopulmonary dysplasia (BPD) in...
